Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
02/1998
02/04/1998CN1172116A Aprotinin variants having improved properties
02/03/1998US5714667 Mice lacking expression of CTLA-4 receptor
02/03/1998US5714593 Vaccines, medical diagnosis
02/03/1998US5714590 Process for recovering a high-purity virus-inactivated factor VIII by anion exchanger chromatography
02/03/1998US5714589 Method of selectively extracting osteogenic protein
02/03/1998US5714588 Enhancement of cellular attachment using H3 protein
02/03/1998US5714585 Antibodies that are immunoreactive with interleukin-7
02/03/1998US5714584 Cross-linked oxygen binding proteins
02/03/1998US5714582 Invertebrate type V telopeptide collagen, methods of making, and use thereof
02/03/1998US5714581 Antitumor agents, leukemia treatment
02/03/1998US5714580 Trypsin Inhibitors
02/03/1998US5714578 Human derived monocyte attracting purified protein product useful in a method of treating infection and neoplasms in a human body
02/03/1998US5714577 Antimicrobial peptides
02/03/1998US5714576 Administering to stimulate melanin synthesis
02/03/1998US5714518 HIV protease inhibitors and methods of making the same
02/03/1998US5714499 Inhibitors ot thrombin
02/03/1998US5714497 Compounds bearing sulphamoyl and amidino radicals, their preparation process and pharmaceutical compositions containing them
02/03/1998US5714485 Piperidine and hexahydropyridazine thrombin inhibitors
02/03/1998US5714484 α-(1,3-dicarbonylenol ether) methyl ketones as cysteine protease inhibitors
02/03/1998US5714471 Useful in indicating neurodegenerative disorders characterized by deposition of cerebral amyloid
02/03/1998US5714470 Pentafluoro alkyl terminated peptide derivatives; treatment of inflammatory diseases, emphysema and chronic bronchitis
02/03/1998US5714469 Administering to animal an oligopeptide and an antibiotics
02/03/1998US5714468 Injecting neurotoxins into localized pain sites
02/03/1998US5714467 Antibacterial and antimalarial hybrid peptides
02/03/1998US5714466 Method of using acylation stimulating protein
02/03/1998US5714465 Method of inhibiting tumor cell dissemination with a metalloproteinase inhibitor
02/03/1998US5714464 Anti-viral mushroom extracts
02/03/1998US5714463 Use of growth factor and antimetabolite combination to prevent or retard fistula closure following glaucoma filtration surgery
02/03/1998US5714462 Cd4 anti-retroviral activity potentiated by the addition of h2 histone or h2 histone-like protein; human immunodeficiency virus
02/03/1998US5714461 Medicinal compositions for the improvement of blood coagulation comprising TCF-II
02/03/1998US5714460 Treating neural damage suffered after central nervous system injury by administering insulin-like growth factor-1
02/03/1998US5714459 Administering to treat demyelination in mammals
02/03/1998US5714458 Includes a bulking agent and either an alkali metal salt of a carboxyalkyl cellulose or a polyoxyethylene sorbitan fatty acid ester and cysteine
02/03/1998US5714382 Isolated dna encoding feline interferon precursor having specified amino acid sequence
02/03/1998US5714381 DNA encoding human alpha 1 adrenergic receptors and uses thereof
02/03/1998US5714372 Tissue plasminogen activator variants
02/03/1998US5714370 Pharmaceutical preparation comprising virus-safe human or animal thrombin, coagulatively active salt
02/03/1998US5714353 Safe vectors for gene therapy
02/03/1998US5714342 Using fluorescence analysis
02/03/1998US5714334 Gene and method for production of an IgA binding protein
02/03/1998US5714331 Incorporating an aminoalkyl side chain into the pna's which bind to complementary nucleobase sequences more tightly to form ?duplexes?; viricides; anticarcinogenic agents; enzyme inhibitors
02/03/1998US5714316 Chimeric envelope proteins for viral targeting
02/03/1998US5714170 Antisense therapy administered by inserting a tumor cell-containing diffusion chamber into a mammal; side effect reduction
02/03/1998US5714169 Live yeast cell derivative
02/03/1998US5714167 Reversibly forming supramolecular complex of active agent with perturbant; drug delivery
02/03/1998US5714166 Bioactive and/or targeted dendrimer conjugates
02/03/1998US5714152 Herpes simplex virus VP16 vaccines
02/03/1998US5714147 Binding endothelial cell with a fused lymphocyte homing receptor polypeptide to prevent the binding of a lymphocyte
02/03/1998US5714146 Increasing osteoblast activity in mammal exhibiting decreased bone formation by administering interleukin-4 antagonist; osteoporosis treatment
02/03/1998US5714145 Tissue plasminogen activator having zymogenic or fibrin specific properties
02/03/1998US5714144 A glycoprotein having high mannose oligosaccharide substituted on a polypeptide; thrombolytic agent; anticoagulants for treating cardiovascular disorders
02/03/1998US5714143 Use of manganese superoxide dismutase (MN-SOD) for preparing pharmaceutical compositions for low-dose treatment of diseases
02/03/1998US5714141 Use of interleukin 7 to enhance humoral immunity
02/03/1998US5714140 Method for inhibiting the production of bioactive IL-1 by administering M-CSF
02/03/1998US5714138 Polyaspartamide derivatives as adsorbents for bile acids, polyaspartamide derivatives loaded with bile acids and process for their preparation and their use as pharmaceuticals
02/03/1998US5714042 A paper sheet or board prepared from a mixture of solubilized collagen and cellulosic pulp (virgin, broke or reclaimed) with good tensile, burst and tear strength
02/03/1998US5713891 Used to heal wounds
02/03/1998CA1339659C Effective antagonists of the luteinizing hormone releasing hormone which release negligible histamine
01/1998
01/29/1998WO1998003873A1 Treatment and diagnosis of cancer
01/29/1998WO1998003872A2 Immunological process for detecting antibodies directed towards tissue transglutaminase (ttg), use of ttg for diagnostic purposes and therapy control, and oral pharmaceutical agent containing ttg
01/29/1998WO1998003870A1 Diagnostic and therapeutic nucleotide or nucleoside photoaffinity compound modified antibodies, and use thereof
01/29/1998WO1998003670A1 Induction of t cell tolerance using a soluble molecule that can simultaneously block two costimulatory pathways
01/29/1998WO1998003665A1 Human kallikrein
01/29/1998WO1998003661A2 Antimicrobial agents, diagnostic reagents, and vaccines based on unique apicomplexan parasite components
01/29/1998WO1998003657A1 Viral interleukin-6
01/29/1998WO1998003654A2 High-affinity interleukin-4 muteins
01/29/1998WO1998003652A2 P300/cbp-associated transcriptional co-factor p/caf and uses thereof
01/29/1998WO1998003650A1 Ninjurin
01/29/1998WO1998003648A1 Fas ligand-like protein, its production and use
01/29/1998WO1998003647A2 Use of recombinant myelin protein for treating t-cell-mediated autoimmune diseases of the peripheral nervous system
01/29/1998WO1998003646A1 Compositions and methods for treating specific gene expression-related diseases and disorders in humans
01/29/1998WO1998003642A1 Protease and related nucleic acid compounds
01/29/1998WO1998003632A1 Bivalent agonists for g-protein coupled receptors
01/29/1998WO1998003572A1 Antiviral linear polymers
01/29/1998WO1998003552A2 A multivalent major histocompatibility complex peptide fusion protein for modulating specific t cell function
01/29/1998WO1998003551A1 Cd6 ligand
01/29/1998WO1998003549A1 MELATONIN 1a RECEPTOR GENE REGULATORY REGIONS AND USES THEREOF
01/29/1998WO1998003547A1 Antagonists of intestinotrophic glp-2 peptides
01/29/1998WO1998003546A1 Analogs of cationic proteins
01/29/1998WO1998003545A1 Protein and gene for antioxidant response
01/29/1998WO1998003544A1 IDENTIFICATION OF SHORT PEPTIDE SEQUENCES REPRESENTING EPITOPES OF GLYCOPROTEIN G OF HSV-2 USING A PHAGE PEPTIDE DISPLAY LIBRARY FOR USE IN AN ANTI-gG2 ELISA
01/29/1998WO1998003543A1 Identification of short peptide sequences representing epitopes of glycoprotein g of hsv-2 using a phage peptide display library
01/29/1998WO1998003541A1 Conantokins
01/29/1998WO1998003539A1 G-protein coupled receptor hnfds78
01/29/1998WO1998003538A2 Signal-regulated, cleavage-mediated toxins
01/29/1998WO1998003534A1 Calcitonin gene-related peptide receptor component factor (houdc44)
01/29/1998WO1998003533A1 Antisense oligonucleotides as antibacterial agents
01/29/1998WO1998003195A1 Methods and compositions for modulation of growth response
01/29/1998WO1998003194A2 Substance p treatment for immunostimulation
01/29/1998WO1998003192A1 Cyclic peptides having broad spectrum antimicrobial activity
01/29/1998WO1998003191A1 Calpain inhibitors for the treatment of cerebral ischemia, spinal cord injury or stroke
01/29/1998WO1998003190A1 Calpain inhibitors for the treatment of traumatic brain injury
01/29/1998WO1998003189A1 Use of conantokins
01/29/1998WO1998003187A1 Proendothelin and hemoglobin in the treatment of acute hemorrhage
01/29/1998WO1998003183A1 Use of 5,6-dihydro-5-azacytidine in the treatment of prostate cancer
01/29/1998WO1998003176A1 Treatment of feline infections peritonitis by an antiviral
01/29/1998WO1998003175A1 Treatment of obesity
01/29/1998WO1998003059A1 Galanin
01/29/1998WO1997046253A3 Immunotherapy for autoimmune disease
01/29/1998WO1997044463A3 Identification and cloning of a mycobacterial antigen corresponding to a heparin-binding haemagglutinin